Company news
KRTL Holding Group, Inc news in 2025
KRTL Holding Group, Inc's news releases, calls and decks from 2025, newest first.
KRTL Biotech Highlights Ophthalmic Pharmaceutical Capabilities to Address Vision Care Needs in Emerging and Global Markets
November 20, 2025
KRTL Holding Group Inc. reports third quarter 2025 results (unaudited) and files PCAOB-audited 2024 and 2023 financial statements
November 17, 2025
KRTL Holding Group Inc. Publishes Investor Presentation
November 11, 2025
KRTL Biotech Highlights Anti-Allergy and Respiratory Product Capabilities to Address Global Market Needs
November 5, 2025
KRTL Holding Group Highlights Bolivian Innovation CaviGuard, Manufactured by SIGMA, as Global Model in Non-Invasive Dental Care
November 3, 2025
Correction: KRTL Holding Group Congratulates SIGMA on National Recognition for Pharmaceutical Excellence in Bolivia
October 29, 2025
KRTL Holding Group Congratulates SIGMA on National Recognition for Pharmaceutical Excellence in Bolivia
October 29, 2025
KRTL Biotech Spotlights Anti-Infectives and Antibiotics Portfolio to Support Public Health and Global Treatment Access
October 28, 2025
KRTL Holding Group Provides Corporate Update: SIGMA Integration, Regulatory Progress, and PCAOB Audit Engagement
October 22, 2025
KRTL Biotech Showcases Gastrointestinal Health Portfolio to Address Global Demand for Accessible Digestive Care
October 20, 2025
KRTL Biotech to Expand Pain Management Reach into U.S. and Global Healthcare Markets
October 15, 2025
KRTL Biotech Advances Global Access to Women’s Health Pharmaceuticals Through Strategic Portfolio Expansion
October 13, 2025
Patricia Wilstermann: A Trailblazing Leader Transforming Bolivia’s Pharmaceutical Industry
October 8, 2025
KRTL Biotech Highlights Pediatric Product Line to Support Childhood Wellness and Global Public Health
October 6, 2025
KRTL Biotech Highlights ELIXIR as Flagship Hydration Product in Bolivia
October 2, 2025
KRTL Biotech Launches Nutraceuticals Initiative in Partnership with SIGMA and Bolivian Health Programs
September 29, 2025
KRTL Biotech Inc. Introduces Expanded Pharmaceutical Portfolio Following Strategic Acquisition
September 24, 2025
KRTL Holding Highlights SIGMA’s 50-Year Legacy of Innovation, Quality, and Community Leadership in Bolivia
September 22, 2025
KRTL Holding Group, Inc. Announces Merger with Industria Químico Farmacéutica Sigma Corp. S.R.L.
September 9, 2025
KRTL Holding Group, Inc. Reports Strong Year-Over-Year Growth for Second Quarter 2025
August 14, 2025
KRTL Biotech Inc. Strengthens Import Operations with Official Customs Broker Appointment, Paving the Way for Global API Expansion
July 30, 2025
KRTL Holding Group Inc. (OTC: KRTL) Bolsters Corporate Leverage with Trademark Recognition and Structural Integration
July 1, 2025
KRTL Biotech Inc. Advances API Supply Chain Strategy with $240,000 Initial Purchase Order
June 11, 2025
KRTL Holding Appoints Dave Orn and Rick Haxton to Accelerate Global Growth at KRTL Biotech Inc.
June 4, 2025
KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative
June 4, 2025
KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
April 8, 2025
KRTL Holding Group, Inc Commences Trading on Upstream Under KRTL
April 1, 2025
KRTL Holding Group Reports 2024 Financial Results and Advances Toward International Pharmaceutical Integration
March 31, 2025
KRTL Holding Group, Inc Approved to Dual List on Upstream
March 25, 2025
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 23, 2025
KRTL Biotech Implements MasterControl QMS to Enhance Regulatory Compliance and Pharmaceutical Importation Readiness
March 3, 2025
KRTL Holding Group Inc. Appoints Philip Polito to Board of Directors as Chief Strategy Officer
February 12, 2025
KRTL Holding Group Inc. Appoints Marlen Patricia Wilstermann-Sanzetenea as International Pharmaceutical Sales Director
February 12, 2025
KRTL Holding Group Inc. Welcomes Dr. Marcelo Bascope as Chief International Science Director
February 12, 2025
KRTL Holding Group Expands in Bolivia: A Strategic Leap for Biopharmaceutical Innovation
February 4, 2025
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
January 21, 2025
KRTL Holding Group Inc. Announces FDA FEI and NDC Certification Achievements by Wholly Owned Subsidiary KRTL Biotech Inc.
January 15, 2025
KRTL Holding Group Inc. (OTC: KRTL) Announces Launch of New KRTL Biotech Website to Streamline Pharmaceutical Industry Solutions
January 7, 2025
KRTL Holding Group Inc. Announces KRTL Biotech Inc. Acquires 55% Majority Stake in Nutrivance Global to Enhance API Distribution and Real-World Data Capabilities
January 7, 2025